Episode Details
Back to Episodes
Canada Trials Ebola Vaccine for Congo Outbreak | Edmonton News
Description
Canada just approved Moderna’s new Ebola vaccine targeting the deadly Bundibugyo strain ravaging the DRC, where over 1,700 have died. Using proven mRNA tech from its COVID-19 shots, the first trials will test safety and dosage in healthy volunteers — while Canada also agreed to manufacture the vaccine locally. With no approved treatments or vaccines for this variant yet, this move is critical. Meanwhile, Hilleman Labs’ rVSV Bundibugyo and Oxford’s AstraZeneca-based candidate are also advancing, as the outbreak continues to spread through bodily fluids and cause hemorrhagic fever.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/272c82cb66e6d050